<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01830296</url>
  </required_header>
  <id_info>
    <org_study_id>MDHTRKTN13</org_study_id>
    <nct_id>NCT01830296</nct_id>
  </id_info>
  <brief_title>Intravenous Remifentanil Plus Morphine or Morphine Alone for Postthoracotomy Pain</brief_title>
  <official_title>COADMINISTRATION OF INTRAVENOUS REMIFENTANIL AND MORPHINE FOR POSTTHORACOTOMY PAIN; COMPARISON WITH IV MORPHINE ALONE</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cukurova University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cukurova University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background; Post-thoracotomy pain remains a major problem. This double-blind, randomized
      study tested the effects of coadministration of patient controlled remifentanil+morphine
      combination on postthoracotomy pain, analgesic consumption and side effects compared with
      morphine PCA alone
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methods; Sixty patients were allocated randomly to receive an intravenous patient-controlled
      analgesia with morphine alone (M), or morphine plus remifentanil (MR), in a double-blind
      manner. Postoperatively patients were allowed to use bolus doses of morphine (0.2 mg kg-1) or
      morphine (0.2 mg kg-1) plus remifentanil (0.2 µg kg-1) mixture every 10 min without a
      background infusion. Pain, discomfort, sedation scores, total and bolus patient-controlled
      morphine consumption, rescue analgesic requirement and side-effects were recorded for up to
      24 h after the start of patient-controlled analgesia.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>COADMINISTRATION OF INTRAVENOUS REMIFENTANIL AND MORPHINE FOR POSTTHORACOTOMY PAIN; COMPARISON WITH IV MORPHINE ALONE</measure>
    <time_frame>Two years</time_frame>
    <description>As aim of this study was to evaluate the effects of remifentanil addition to morphine for i.v. PCA on analgesic consumption, the primary endpoint was defined as morphine consumption at 24 hour.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Remifentanil+Morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Morphine(M) Remifentanil+Morphine(MR)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IV morphine PCA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IV remifentanil+morphine PCA</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil+morphine</intervention_name>
    <description>Morphine, Remifentanil+Morphine</description>
    <arm_group_label>Remifentanil+Morphine</arm_group_label>
    <arm_group_label>IV morphine PCA</arm_group_label>
    <other_name>Morphine Group (M)</other_name>
    <other_name>Remifentanil+Morphine Group (MR)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  60 ASA physical status I-III patients, between the ages of 18 and 59 years, scheduled
             for elective thoracotomy surgery with general anaesthesia were included in this study

        Exclusion Criteria:

          -  severe hepatorenal disease history, sensitivity or contraindication to morphine and
             remifentanil, chronic pain (defined as regular use of opioid analgesics for &gt; 3
             months), drug or alcohol abuse and contraindication to administration of PCA
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>59 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mediha Turktan, Assist Prof</last_name>
    <role>Study Director</role>
    <affiliation>Cukurova University, Department of Anaesthesiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hakkı Unlugenc</name>
      <address>
        <city>Adana</city>
        <zip>01330</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 27, 2013</study_first_submitted>
  <study_first_submitted_qc>April 10, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 12, 2013</study_first_posted>
  <last_update_submitted>April 10, 2013</last_update_submitted>
  <last_update_submitted_qc>April 10, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 12, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cukurova University</investigator_affiliation>
    <investigator_full_name>Hakki Unlugenc</investigator_full_name>
    <investigator_title>Prof Dr.</investigator_title>
  </responsible_party>
  <keyword>Postthoracotomy pain,</keyword>
  <keyword>patient controlled analgesia,</keyword>
  <keyword>remifentanil and</keyword>
  <keyword>morphine.</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

